Get started
Author

Rosaly A. Buiten

Observed names: Buiten, Rosaly, R A Buiten, R. A. Buiten, R.A Buiten, R.A. Buiten, Rosaly A Buiten, Rosaly Anne Buiten, Rosaly Buiten
ORCID: 0000-0002-7385-0634
Observed ORCID: 0000-0002-7385-0634
OpenAlex ID: A5064887206
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
2018 · Clemens von Birgelen, Paolo Zocca, et al. · The Lancet · 144
PDF
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels
2019 · Rosaly A. Buiten, Eline H. Ploumen, et al. · JAMA Cardiology · 72
Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents
2019 · Rosaly A. Buiten, Eline H. Ploumen, et al. · JACC: Cardiovascular Interventions · 58
PDF
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial
2018 · Marlies M. Kok, Paolo Zocca, et al. · EuroIntervention · 52
PDF
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years
2020 · Rosaly A. Buiten, Eline H. Ploumen, et al. · JACC: Cardiovascular Interventions · 40
PDF
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
2022 · Eline H. Ploumen, Tineke H. Pinxterhuis, et al. · Journal of the American Heart Association · 30
PDF
First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial
2021 · Eline H Ploumen, Rosaly A Buiten, et al. · Circulation Journal · 23
PDF
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
2020 · Rosaly A. Buiten, Eline H. Ploumen, et al. · Catheterization and Cardiovascular Interventions · 19
PDF
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
2019 · Eline H. Ploumen, Rosaly A. Buiten, et al. · Catheterization and Cardiovascular Interventions · 12
PDF
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
2020 · Eline H. Ploumen, Rosaly A. Buiten, et al. · International Journal of Cardiology · 10
PDF
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms
2022 · Jacopo Burrello, Guglielmo Gallone, et al. · Journal of Personalized Medicine · 9
PDF
Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents
2020 · Rosaly A. Buiten, Paolo Zocca, et al. · Current Opinion in Cardiology · 9
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
2020 · H. Kawashima, P. Zocca, et al. · Netherlands Heart Journal · 9
PDF
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials
2020 · Eline H. Ploumen, Rosaly A. Buiten, et al. · American Heart Journal · 8
PDF
Superiority of biodegradable polymer sirolimus-eluting stents in STEMI
2019 · Clemens von Birgelen, Rosaly Anne Buiten · The Lancet · 8
PDF
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
2021 · Eline H. Ploumen, Rosaly A. Buiten, et al. · Catheterization and Cardiovascular Interventions · 6
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents
2020 · Ariel Roguin, Rosaly A. Buiten, et al. · JACC: Cardiovascular Interventions · 6
PDF
Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial
2020 · Rosaly A. Buiten, Sanne Warta, et al. · Coronary Artery Disease · 5
PDF
Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent
2024 · Daphne van Vliet, Eline H. Ploumen, et al. · Catheterization and Cardiovascular Interventions · 4
Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate
2023 · Rosaly A Buiten, Eline H Ploumen · The Lancet · 3
Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years
2024 · Eline H. Ploumen, Martijn J. Oude Wolcherink, et al. · PharmacoEconomics - Open · 2
PDF
Ultrathin Strut Stents in Small Coronary Vessels—Are We There Yet?—Reply
2019 · Rosaly A. Buiten, Eline H. Ploumen, et al. · JAMA Cardiology · 2
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease – a secondary analysis of the randomized TWENTE trials
2025 · Daphne van Vliet, Tineke H. Pinxterhuis, et al. · IJC Heart & Vasculature · 1
Preferred Treatment and Expected Risk in Coronary Intervention Patients With Peripheral Arterial Disease: Cardiologists’ Views Versus Trials Data
2025 · Tineke H. Pinxterhuis, Clemens von Birgelen, et al. · CJC Open · 1
PDF
Ten-year survival after stenting the proximal left anterior descending coronary artery with new-generation drug-eluting stents
2026 · Daphne van Vliet, Antonia Dayal, et al. · Cardiovascular Intervention and Therapeutics
PDF
Works count: 34
Citation count: 533
H-index: 10
I10-index: 10
Year
Topic
Type